All Articles

The Korean biopharma giant is leveraging its biosimilar success to fund a major push into cutting-edge cancer therapies and advanced drug platforms.

A Markham manufacturer is tripling its transformer production, creating 150 jobs and tackling a critical shortage threatening North America's energy future.

Ameriprise Financial's top rank on TIME's 'Iconic Companies' list reveals a story of strategic independence, tech innovation, and enduring reputation.

Recruitment firm HireClix launches a new tool to bypass tedious logins and forms, aiming to fix the high rate of candidate application abandonment.

Lead Capital Partners' strategic investment in PedsOne signals a growing focus on specialized services that help independent doctors navigate financial pressures.

The digital marketing giant acquires GURU Conference and SubjectLine.com, betting on education and community to empower small businesses.

The firm's recognition highlights a market shift toward AI-driven quality assurance. What does this mean for enterprises seeking to innovate and reduce risk?

Golconda Gold appoints a new GM to restart its New Mexico mine, a strategic move to unlock over 1M ounces of annual silver production and diversify its portfolio.

With a fresh $40M, Innventure is cleaning its books and deepening its investment in Accelsius, whose tech is vital for the future of AI.

Canary Technologies' top award for its AI Voice signals a major shift, turning hotel call centers from cost centers into 24/7 revenue-generating engines.

A Brazilian tech firm won a $1M prize for its groundbreaking AI that hears water leaks, tackling a global crisis and saving billions of liters daily.

UiPath's agentic AI, powered by Claude Opus 4.5, has secured the top spot on a crucial industry benchmark, validating its enterprise-readiness.

As Moelis & Co. prepares to report its 2025 results, investors are watching to see if the firm capitalized on a record year for dealmaking.

GCE sets its Q4 earnings date. Investors eye enrollment, margins, and its 2026 outlook as the education services giant navigates a shifting market.

The newly public homebuilder appoints its first CIO, signaling a strategic push to leverage technology for growth and innovation in a competitive market.

Spire's upcoming Feb. 3 earnings call is under scrutiny as investors weigh a massive $11.2B investment plan against ambitious growth targets.

As MarketAxess preps its Q4 results, investors weigh a mixed 2025. Will its strategic shifts in a volatile fixed-income market deliver on growth promises?

As Helmerich & Payne preps its Q1 2026 earnings call, investors are watching if its tech focus can overcome soft rig demand and cautious market signals.

Flashpoint Therapeutics appoints an FDA-approved drug developer as CSO, a strategic move to accelerate its groundbreaking structural nanomedicine platform.

A U.S. Appeals Court upheld a massive award to DXC Technology, finding Tata Consultancy Services willfully stole trade secrets in a landmark IP ruling.